No Detail Found!

Lauric acid: Its role in behavioral modulation, neuro-inflammatory and oxidative stress markers in haloperidol induced Parkinson's disease

Author(s)
Awais Ali Zaidi Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Mahtab Ahmad Khan Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,PakistanFaculty of Pharmacy, University of Central Punjab,Lahore,Pakistan
Zaib Ali Shahreyar Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Hammad Ahmed Department of Pharmacology, Faculty of Pharmacy, The University of Lahore,Lahore,Pakistan
Abstract
The study was designed to investigate the neuro-protection of lauric acid (LA) on haloperidol (HPD) induced Parkinson's disease (PkD) rat model. Rats were divided into group A (normal), group B (diseased, by HPD 1mg/kg i.p. for 14 days), group C (standard treatment, levodopa 30 mg/kg), group D (vehicle coconut oil 1ml/kg), group E (LA 0.66mg/kg) and group F (LA 1.32mg/kg) for 35 days after induction of PkD. The study displayed a state of oxidative stress in the striatum of rat model of PkD as shown from the increased MDA, NO levels and the decreased superoxide dismutase levels. HPD caused an increase in tumor necrosis factor-a level, NF-?B, IL-8 mRNA expression and suppress IL-4 expression. Neuro-protection with LA attenuated the oxidative stress and changes in pro-inflammatory cytokines induced due to PkD induction. The LA treatment also showed improvement in the histo-pathology of the rats' brain. LA also improved behavioral performances, food intake, weight gain as compared to animal of diseased group and prevented decline in motor activities (assessed Rotarod, and Beam walking test). LA showed significant neuro-protection against oxidative stress, inflammatory cytokines and behavioral changes in HPD induced rat model of PkD.
Publication Details
Page(s) 755-763
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP2, Year: 2020

Request the full text from PASTIC

Keywords
Parkinson's disease, Dopamine, Reactive oxygen species, substantia nigra, Neuro-inflammation
References
Angelova PR,Abramov AY .2018 .Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett, 592(5) : 692-702.
Bartus RT,Pt B .2017 .Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next? Neurobiol. , 97 : 169-178.
Bueno-Nava A,Gonzalez-Pina R,Alfaro-Rodriguez A,Nekrassov-Protasova V,Durand-Rivera A,Montes S,Ayala-Guerrero F .2010 .Recovery of motor deficit, cerebellar serotonin and lipid peroxidation levels in the cortex of injured rats. Neurochem. Res., 35(10) : 1538-1545.
Cheema MAR,Nawaz S,Gul S,Salman T,Naqvi S,Dar A,Haleem DJ A .2018 .Neurochemical and behavioral effects of Nigella sativa and Olea europaea oil in rats. Nutr, 21(3) : 185-194.
Deleu D,Northway MG,Hanssens Y .2002 .Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.. , : .
. .. Clin. Pharmacokinet, 41(4) : 261-309.
Pak. J. Pharm. Sci. .2000 .Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. JAMA, 284(15) : 1931-1938.
Hirtz D,Thurman D,Gwinn-Hardy K,Mohamed M,Chaudhuri A,Zalutsky R .2007 .How common are the “common” neurologic disorders?. Neurology, 68(5) : 326-337.
Holloway R,Shoulson I,Fahn S,Kieburtz K,Lang A,Marek K,Mcdermott M,Seibyl J,Weiner W,Musch B .2004 .Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year randomized controlled trial. Arch Neurol, 61(7) : 1044-1053.
Hutter-Saunders JA,Gendelman HE,Mosley RL .2012 .- tetrahydropyridine (MPTP) intoxication. -phenyl-1, (3) : .
Pharmacol Neuroimmune . .. , 7(1) : 279-288.
Jin F,Wu Q,Lu YF,Gong QH,Shi JS .2008 .. , : .
. .Neuroprotective effect of resveratrol on 6-OHDAinduced Parkinson's disease in rats. Eur. J. Pharmacol., 600(1-3) : 78-82.
Jomova K,Vondrakova D,Lawson M,Valko M M .2010 .Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem, 345(1-2) : 91-104.
Khadrawy YA,Salem AM,El-Shamy KA,Ahmed EK,Fadl NN,Hosny EN .2017 .Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson's disease induced by rotenone. J. of Diet., : .
Suppl. . .. , 14(5) : 553-572.
Kim GH,Kim JE,Rhie SJ,Yoon S SJ .2015 .The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol, 24(4) : 325-340.
Lundblad M,Vaudano E,Cenci M .2003 .Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. J. Neurochem., 84(6) : 1398-1410.
Mccarty MF,Dinicolantonio JJ .2016 .Lauric acidrich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity. Open Heart, 3(2) : e000467.
Montgomery SL,Bowers WJ .2012 .Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol, 7(1) : 42-59.
Mumme K and Stonehouse W .2015 .Effects of mediumchain triglycerides on weight loss and body composition: A meta-analysis of randomized controlled trials. J, Acad, Nutr, 115(2) : 249-263.
Phatnani H and Maniatis T .2015 .Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol, 7 : a020628.
Ruiz-Larrea MB,Leal AM,Liza M,Lacort M and De Groot H M .1994 .Antioxidant effects of estradiol and 2- hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids, 59(6) : 383-388.
Salamone JD,Correa M .2002 .Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. , : .
Behav. Brain. Res. . .. , 137(1-2) : 3-25.
Shin HW,Chung SJ .2012 .Drug-induced parkinsonism. J. Clinic. Neuro., 8(1) : 15-21.
Tang J,Hu ZY,Chen XW .2007 .Free radical scavenging and antioxidant enzymes activation of polysaccharide extract from Nostoc sphaeroides. , : .
. .. of Chin. Med, 35(05) : 887-896.
Tansey MG,Goldberg MS .2010 .Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis, 37(3) : 510-518.
Valenti O,Gill KM,Grace AA .2012 .Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: Response alteration by stress pre-exposure. Eur. J. Neurosci., 35(8) : 1312-1321.
Zaidi AA,Shakir L,Khan TA,Khan MA,Ali A,Rehman AU .2016 .Haloperidol leads to torse de pointes in schizophrenic pool. E. J. of Pharma. A Med, : .
Res . .. , 3(10) : 84-91.
0

Citations

0

Downloads

8

Views